Natural products have served as the source or architectural inspiration for countless drug discovery efforts. In the eld of oncology for instance, around half of all nal drug entities were either natural products or directly derived from them during the past 70 years.
1 This could be due to their pre-validated biological relevance and coverage of different regions of chemical space. 2 More recently, natural products from the marine world have been subject to extensive exploration and yielded compounds that have become clinically approved therapeutics such as ziconotide and trabectedin.
3 Marine derived fungal metabolites have become an important new avenue of research in identifying novel structures with potential bioactivity from spores and cultures.
Connected to our other efforts in medicinal chemistry we became interested in exploring novel nitrogen based heterocycles as new scaffolds. 4 Recently, the isolation and spectral characterisation of the rst naturally occurring example of an imidazo[1, 5-b] isoquinoline-1,3,5(2H)-trione alkaloid (1, Fig. 1 ) from the mangrove fungus, Hypocrea virens has been reported by Hua and co-workers. 5 Subsequently, Davies and co-workers have reported a single example of the related, 7-phenoxyimidazo[1, 5-b] isoquinoline-1,3,5(2H)-trione skeleton (2, Fig. 1 ) that exhibits sub-micromolar potency for inhibition of the proto-oncogene serine/threonine-protein kinase, PIM1 (IC 50 ¼ 804 nM AE 37 nM). Despite the apparent simplicity of 1, there have been no conrmatory syntheses reported to date of this mangrove alkaloid. Intrigued by both the structure of 1 and the recently reported bioactivity of a related analogue, we pursued a synthetic campaign to alkaloid 1.
Our initial approach to 1 envisioned a concise route; a double Knoevenagel and amide bond disconnection to 2-carboxybenzaldehyde 3 and 3-methylimidazolidine-2,4-dione 6 (Scheme 1). 6 in turn, could be prepared via a regioselective N3-alkylation of hydantoin with dimethylacetal dimethylacetamide (DMADMA) in 53% isolated yield.
7 The reaction of 2-carboxybenzaldehyde 3 and a related hydantoin analogue, thiohydantoin 4a has previously been reported to afford the related heterocyclic scaffold 5a (Scheme 1). 8 However, treatment of 6 with 2-carboxybenzaldehyde 3 failed to deliver 1, instead an isobenzofuranone derivative 7 was afforded in 42% isolated yield. The connectivity of 7 was unambiguously assigned using a 1 H-13 C HMBC experiment (Scheme 1, inset). 9 Other instructive spectral measurements included the splitting of the methylene signal in the 1 H NMR spectrum, indicating diastereotopic protons which was conrmed by 1 H-13 C HSQC NMR. 9 Conclusive evidence for the structure of 7 was obtained by small molecule X-ray crystallography (Scheme 1, inset).
10 There are limited reports for the preparation of this isobenzofuranone derivative.
11 In summary, unusual reactivity of hydantoin gave an unexpected reaction product compared to thiohydantoin with 2-carboxybenzaldehyde (Scheme 1).
12 Attempts to intercept the reaction pathway via a protecting group strategy or sequentially performing the Knoevenagel step and the amide formation were also not successful.
We therefore sought to use the tricyclic manifold of 5b as a rapid entry to 1 via a desulfurisation approach. Stoichiometric strategies to convert thioamides and thioureas to amides or ureas, respectively are well known.
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On simple monofunctionalised thioamides a desulfurisation route using a photo-redox catalyst has been reported.
14 Employing a photosynthetic route using Eosin-Y and green LEDs enabled the modest preparation of 1 but to the best of our knowledge this is the rst report in a more complex heterocyclic setting (solvent and UV/vis studies are shown in the ESI).
9 Alternatively, a twostep methylation and hydrolysis route also delivered 1 in an improved yield (Scheme 2).
To our delight, compound 1 crystallised upon standing in CDCl 3 . Small molecule X-ray crystallography (Scheme 2) Scheme 2 Two alternative desulfurisation routes to the reported mangrove alkaloid 1 and single crystal X-ray structure of 1 (inset). a These d C values were reported to be interchangeable. 5 conrmed the preparation of structure 1. However, comparison of our NMR spectroscopic data with the originally reported 5 revealed important disparities (Table 1) . It became obvious by comparison of the NMR spectral data that the isolated example of 1 differed from that of synthesised 1 (Table 1 ). In particular, in the 1 H NMR spectrum the location of the C10-H (+0.35 ppm) and N2-methyl group (+0.20 ppm) in isolated 1 vs. synthesised 1, respectively. Intriguingly, in the original report 5 the amide, urea and arylamide 13 C NMR spectral carbonyl shis were all reported to be within AE0.1 ppm, which would be highly unlikely in the claimed structure.
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Furthermore, our synthesised example of 1 more closely replicates the known ethyl derivative reported by Niopas and Smail, in particular the location of the C10-H. 16 It was therefore shown by both NMR spectroscopy and conrmation of the small molecule X-ray crystal structure that the previously isolated natural product had different connectivity. Therefore, taking account of all of the above it was proposed that the isolated structure claimed as 1, was in actual fact structural isomer 9 a metabolite of the gliotoxin family (Fig. 2) .
Furthermore, other metabolites isolated from Hypocrea virens and related mangrove fungi include gliotoxin derivatives demonstrating a potential common biosynthetic pathway.
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Compound 9 is a natural product recently isolated from the marine fungus Neosartorya pseudoscheri with NMR spectral data reported in d 6 -DMSO. 18 In order to compare the spectra of 9 with the isolation data associated with the claimed structure of 1, a total synthesis and NMR spectra measurement in CDCl 3 was required (Scheme 3), 9 having previously been prepared only via degradation studies of gliotoxin with selenium.
19 Furthermore, the proposed structure 9 held promise, as it has also been reported to be found in isolates from Penicillium terlikowskii.
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Esterication of indole 2-carboxylic acid 10 followed by conversion to the N-methyl amide 12 in water proceeded smoothly. 21 The conversion of 12 to 9 proved more challenging, with closure of the amine and amide motifs onto a range of reported oxalyl derivatives giving mixed results. 22 The use of ethyl chlorooxoacetate proved effective via initial formation of 13 (observed in the crude 1 H NMR aer 1 h at reux) to afford 9 in 41% isolated yield. Comparison of the 1 H and 13 C NMR spectra in CDCl 3 revealed that 9 matched the isolation NMR Fig. 2 The connectivity pattern of the reported isolated material 1 (shown in black) and the most likely structural isomer 9.
Scheme 3 Synthetic route to the proposed natural product 9 and small molecule X-ray crystal structure of 9 (inset). details for the claimed structure of 1 (Table 2) with some subtle differences. The complete structural assignment began from the C6-H due to the effect of being forced into the deshielding cone of the peri-carbonyl group (C4). 23 The 1 H NMR spectral data was in good accordance between synthesised 9 and isolated 1 with <0.02 ppm differences for the C6-H and C10-H. Due to the pulse sequence used further splitting of the aromatic coupling pattern was observed at the 4 J level as expected in a planar W-coupling system. The reported and observed 1 H-13 C HMBC correlations for 9 matched with the isolation data for 1 plus due to the strength of our sample further weak, but in agreement, correlations were observed (Table 2) . Conclusive evidence for the structure of 9 was obtained by the small molecule X-ray crystal structure (Scheme 3, inset).
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In summary, we have shown that the originally isolated natural product 1 through synthesis was gliotoxin derivative 9. We have reported the rst synthesis, combining a photochemical step of the claimed structure of the mangrove alkaloid 1 and through structural revision, completed the rst total synthesis of the revised natural product 9. The reassignment of the natural product isolated from Hypocrea virens opens the door to elucidating the biosynthesis or shunt metabolism of gliotoxin derivatives and provides a new scaffold to investigate the synthesis of gliotoxin family members. The biological evaluation of the reassigned natural product and related family members will be investigated and reported in due course.
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